Dashboard
Manage Tickers

BIO BIO-RAD LABORATORIES, INC.

NYSE bio-rad.com


$ 309.43 $ 0.00 (0 %)    

Wednesday, 05-Nov-2025 09:41:02 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 618.20 $ -0.27 (-0.04 %)
DIA $ 470.48 $ -0.32 (-0.07 %)
SPY $ 674.47 $ -0.53 (-0.08 %)
TLT $ 89.45 $ -0.06 (-0.07 %)
GLD $ 365.98 $ -0.47 (-0.13 %)
$ 310.96
$ 309.87
$ 306.39 x 61
$ 310.96 x 15
-- - --
$ 211.43 - $ 387.99
196,084
na
8.39B
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-29-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-14-2025 12-31-2024 10-K
5 10-31-2024 09-30-2024 10-Q
6 08-02-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 02-16-2024 12-31-2023 10-K
9 10-27-2023 09-30-2023 10-Q
10 08-04-2023 06-30-2023 10-Q
11 05-05-2023 03-31-2023 10-Q
12 02-17-2023 12-31-2022 10-K
13 10-28-2022 09-30-2022 10-Q
14 07-29-2022 06-30-2022 10-Q
15 04-29-2022 03-31-2022 10-Q
16 02-11-2022 12-31-2021 10-K
17 10-29-2021 09-30-2021 10-Q
18 07-30-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-16-2021 12-31-2020 10-K
21 10-30-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 11-01-2019 09-30-2019 10-Q
26 08-06-2019 06-30-2019 10-Q
27 05-10-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 04-16-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-02-2016 09-30-2016 10-Q
38 08-05-2016 06-30-2016 10-Q
39 05-06-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

citigroup-maintains-buy-on-bio-rad-laboratories-raises-price-target-to-375
Citigroup Maintains Buy on Bio-Rad Laborat...
10/30/2025 18:23:03

Citigroup analyst Patrick Donnelly maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and raises the price target from $35...

wells-fargo-maintains-equal-weight-on-bio-rad-laboratories-raises-price-target-to-340
Wells Fargo Maintains Equal-Weight on Bio-...
10/30/2025 14:45:37

Wells Fargo analyst Brandon Couillard maintains Bio-Rad Laboratories (NYSE:BIO) with a Equal-Weight and raises the price tar...

correction-bio-rad-laboratories-q3-adj-eps-226-beats-193-estimate-sales-653000m-beat-651301m-estimate
CORRECTION: Bio-Rad Laboratories Q3 Adj. E...
10/29/2025 21:41:56

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $1....

bio-rad-laboratories-affirms-fy2025-sales-guidance-of-2567b-2593b-vs-2593b-est
Bio-Rad Laboratories Affirms FY2025 Sales ...
10/29/2025 20:18:49

Full-Year 2025 Financial OutlookBio-Rad is maintaining its financial outlook for the full year 2025. The company continues to e...

earnings-scheduled-for-october-29-2025
Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

bio-rad-laboratories-analysts-raise-their-forecasts-after-better-than-expected-q2-earnings
Bio-Rad Laboratories Analysts Raise Their ...
08/01/2025 15:30:23

rbc-capital-maintains-outperform-on-bio-rad-laboratories-raises-price-target-to-409
RBC Capital Maintains Outperform on Bio-Ra...
08/01/2025 15:23:26

RBC Capital analyst Conor McNamara maintains Bio-Rad Laboratories (NYSE:BIO) with a Outperform and raises the price target f...

monolithic-power-systems-workiva-interface-appfolio-and-other-big-stocks-moving-higher-on-friday
Monolithic Power Systems, Workiva, Interfa...
08/01/2025 14:44:18

wells-fargo-maintains-equal-weight-on-bio-rad-laboratories-raises-price-target-to-265
Wells Fargo Maintains Equal-Weight on Bio-...
08/01/2025 14:18:03

Wells Fargo analyst Brandon Couillard maintains Bio-Rad Laboratories (NYSE:BIO) with a Equal-Weight and raises the price tar...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/31/2025 21:07:05

bio-rad-laboratories-narrows-fy2025-sales-guidance-from-2541b-2606b-to-2567b-2593b-vs-2520b-est
Bio-Rad Laboratories Narrows FY2025 Sales ...
07/31/2025 20:20:20

Bio-Rad Laboratories (NYSE:BIO) narrows FY2025 sales outlook from $2.541 billion-$2.606 billion to $2.567 billion-$2.593 billio...

bio-rad-laboratories-q2-adj-eps-261-beats-176-estimate-sales-651600m-beat-615110m-estimate
Bio-Rad Laboratories Q2 Adj. EPS $2.61 Bea...
07/31/2025 20:15:43

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.61 per share which beat the analyst consensus estimate of $1....

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

bio-rad--announces-launch-of-new-droplet-digital-pcr-platforms
Bio-Rad Announces Launch Of New Droplet D...
07/07/2025 13:02:13

5-analysts-have-this-to-say-about-bio-rad-laboratories
5 Analysts Have This To Say About Bio-Rad ...
06/09/2025 21:00:33

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
05/06/2025 17:35:25

ubs-maintains-buy-on-bio-rad-laboratories-lowers-price-target-to-310
UBS Maintains Buy on Bio-Rad Laboratories,...
05/02/2025 22:47:01

UBS analyst Dan Leonard maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and lowers the price target from $355 to $310.

citigroup-maintains-buy-on-bio-rad-laboratories-lowers-price-target-to-350
Citigroup Maintains Buy on Bio-Rad Laborat...
05/02/2025 22:12:21

Citigroup analyst Patrick Donnelly maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and lowers the price target from $40...

rbc-capital-maintains-outperform-on-bio-rad-laboratories-lowers-price-target-to-392
RBC Capital Maintains Outperform on Bio-Ra...
05/02/2025 18:38:36

RBC Capital analyst Conor McNamara maintains Bio-Rad Laboratories (NYSE:BIO) with a Outperform and lowers the price target f...

bio-rad-laboratories-sees-fy25-non-gaap-currency-neutral-revenue-to-rang-from-10-decline-to-15-growth
Bio-Rad Laboratories Sees FY25 Non-GAAP Cu...
05/01/2025 20:20:21

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION